Revelation Biosciences issues stockholder rights dividend under new poison pill plan
REVB•Stockholder rights plan adopted
Revelation Biosciences adopted a stockholder rights plan, issuing one right per common share via a dividend.
- Rights payable to holders of record on July 21, 2026.
- Rights become exercisable if an investor group crosses 10% ownership, or 15% for certain passive institutional investors.
- Each right allows purchase of 1/1,000 of Series B Junior Participating Preferred Stock at an exercise price of $20.
- Rights expire July 10, 2027 unless stockholders approve, extending the term to three years from approval.
